سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

jntl consumer health ii (switzerland) gmbh - cinnarizinum - compresse - cinnarizinum 25 mg, lactosum monohydricum 158.8 mg, maydis amylum, saccharum 15 mg, talcum, gossypii oleum hydrogenatum, povidonum k 90, pro compresso. - calciumantagonist, disturbi circolatori - synthetika

سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - cinnarizinum - gocce - cinnarizinum 75 mg, cellulosum microcristallinum et carmellosum natricum corresp. natrium 0.01 mg, ethanolum 20 mg corresp. ethanolum 2.5 % v/v, polysorbatum 20, sorbitolum liquidum cristallisabile 530 mg, aromatica (banane), propylis parahydroxybenzoas 500 µg, e 218 2 mg, aqua purificata ad suspensionem pro 1 ml corresp. 25 guttae. - calciumantagonist, disturbi circolatori - synthetika

إيطاليا - الإيطالية - AIFA (Agenzia Italiana del Farmaco)

janssen cilag s.p.a. - cinnarizina - cinnarizina

إيطاليا - الإيطالية - AIFA (Agenzia Italiana del Farmaco)

pharmazena srl - cinnarizina - capsule - "75 mg capsule rigide" blister20 capsule

إيطاليا - الإيطالية - AIFA (Agenzia Italiana del Farmaco)

pharmazena s.r.l. - cinnarizina - cinnarizina

إيطاليا - الإيطالية - AIFA (Agenzia Italiana del Farmaco)

link pharm s.r.l. - cinnarizina - cinnarizina

إيطاليا - الإيطالية - AIFA (Agenzia Italiana del Farmaco)

gmm farma s.r.l. - cinnarizina - cinnarizina

سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

allergopharma ag - alimenti allergeni extractum (solanum tuberosum) - pricktestlösung - alimenti allergeni extractum (solanum tuberosum) 5000 u., natrii chloridum, glycerolum, phenolum, aqua ad iniectabile ad solutionem pro 1 ml. - la diagnosi delle allergie - allergeni: prodotto diagnostico

إيطاليا - الإيطالية - Ministero della Salute

pharmafit agt srl soc.agricola -

الاتحاد الأوروبي - الإيطالية - EMA (European Medicines Agency)

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.